Pentedrone

Pentedrone, also known as α-methylaminovalerophenone, is a synthetic cathinone stimulant. It is structurally related to methcathinone and hexedrone, with a propyl side chain attached to the alpha carbon. Pentedrone has been detected in recreational drug products and forensic investigations since the early 2010s. Laboratory studies show strong dopamine-transporter activity and rewarding effects in animal models.

Chemistry and history

Pentedrone is a beta-keto amphetamine with an N-methyl group and a propyl substituent at the alpha carbon. It is the higher homologue of methcathinone and the N-methyl analogue of N-ethylpentedrone. The European monitoring system recorded it among the emerging synthetic cathinones during the early 2010s.

Pharmacology

Pentedrone inhibits monoamine uptake, with a marked preference for the dopamine transporter over the serotonin transporter. In one study, it inhibited dopamine uptake with substantially greater potency than serotonin uptake. It also produced rewarding effects in mice and supported self-administration in rats, indicating reinforcing properties in these models (Pentedrone and dopaminergic activity, 2015).

A later structure–activity study found that pentedrone was strongly selective for DAT over SERT, while N-ethylpentedrone showed even greater DAT potency in the same assay. These findings help explain the stimulant profile of the group but do not establish human potency or dependence risk (Second-generation cathinone study, 2021).

Subjective effects

The PsychonautWiki profile of pentedrone includes anecdotal reports of stimulation, euphoria and increased alertness. These cannot serve as a controlled comparison with other cathinones.

Physical effects

Reported effects include stimulation, increased energy, physical restlessness and increased heart rate. Sweating, reduced appetite, dry mouth, jaw tension and difficulty sleeping are also described. Some accounts mention nausea, dehydration and cardiovascular discomfort.

Cognitive effects

Users report euphoria, faster thoughts, increased motivation and wakefulness. Some describe improved concentration, while others report anxiety, irritability, paranoia or compulsive redosing. The strong dopamine-transporter activity observed in vitro is consistent with stimulant effects, but does not confirm every subjective report.

Clinical and forensic findings

Pentedrone has been identified in clinical and post-mortem toxicology cases, often alongside other stimulants or psychoactive substances. A review of synthetic cathinones emerging between 2019 and 2022 discusses its presence in forensic investigations and the difficulty of interpreting mixed-drug cases (Review of emerging synthetic cathinones, 2022).

The available case literature does not establish a reliable blood concentration threshold for toxicity. Co-ingested substances and differences in sampling time complicate comparisons between cases.

Toxicity and research limitations

Animal studies provide evidence of stimulant and reinforcing effects, but controlled human research is limited. There is no well-established clinical profile for long-term exposure, dependence or withdrawal. The available evidence supports concern about abuse liability, while the frequency and severity of specific adverse effects remain uncertain.

Related compounds

Pentedrone is related to N-Ethylpentedrone, Hexedrone, N-Ethylhexedrone and Methcathinone. It is the N-methyl analogue of NEP and the higher homologue of methcathinone.